1 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18038781 | ORAL SOLID PREPARATION COMPRISING N2-{[1-ETHYL-6-(4-METHYLPHENOXY)-1H-BENZIMIDAZOL-2-YL] METHYL}-L-ALANINAMIDE | KASSA, TIGABU | 1619 | Final Rejection | May 25, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial